🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07611071
Starting soon Not applicable

AI-Integrated Emotional Granularity Training for Resilience and Quality of Life in Colorectal Cancer Survivors

NCT07611071 · tracked via the Priya Life Science China tracker
Sponsor
The Hong Kong Polytechnic University
Phase
Not applicable
Started
2026-06-01
Last updated
2026-06-04

Condition(s) studied

Colorectal Cancer (CRC)

Investigational drug(s) / intervention(s)

Emotional granularity trainingRoutine Care

Emotional granularity training: The 4-week Emotional Granularity Growth intervention (AI-EGG) will be delivered via a structured mobile-based digital platform based on emotional granularity theory and Gross's Extended Process Model of Emotion Regulation. The intervention includes four modules: (1) emotional identification and labeling, (2) emotional differentiation training, (3) emotion regulation strategy selection, and (4) implementation and reflective adaptation. Each session follows a cycle of emotional diary recording, labeling, feedback on emotional differentiation, and practice of regulation strategies. Participants are encouraged to complete at least two sessions per week. Predefined emotional categories and structured vocabulary support consistent labeling. Culturally adapted scenarios for young and middle-aged CRC survivors are included. Oncology nurses provide support, including clarification of emotional concepts, guidance on real-life application, and referral when needed

Routine Care: Routine psychological care will be provided by oncology nurses, along with standard educational materials on symptom management and basic emotional coping strategies consistent with clinical guidelines. Participants will also complete the online questionnaires for outcome assessment.

Study summary

The goal of this clinical trial is to evaluate an AI-integrated Emotional Granularity Growth intervention (AI-EGG) designed to enhance resilience and improve quality of life in young and middle-aged colorectal cancer (CRC) survivors. Emotional granularity refers to the ability to clearly identify and differentiate subtle emotional experiences, which may help individuals regulate emotions more effectively and build resilience after cancer treatment.

The main questions it aims to answer are:

* Does the AI-EGG intervention improve resilience in CRC survivors compared with routine psychological care?
* Does the intervention improve emotional granularity, emotion regulation ability, and quality of life?
* Is the AI-EGG intervention feasible and acceptable for young and middle-aged CRC survivors?

Researchers will compare the AI-EGG intervention group to a control group receiving routine psychological care and standard educational materials to see whether the intervention leads to better psychological outcomes.

Participants will:

* Complete baseline assessments measuring emotional granularity, emotion regulation, resilience, and quality of life
* Be randomly assigned to either the intervention group or the control group
* In the intervention group, engage in a 4-week AI chatbot-based program focusing on emotional identification, differentiation, regulation, and reflective practice (at least two sessions per week)
* In the control group, receive routine psychological care and standard educational materials
* Complete post-intervention assessments immediately after the 4-week program and again at a 1-month follow-up
* Some participants in the intervention group will be invited to complete interviews about their experience of the program

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * (1) young and middle-aged adult patients (age in the range of 18-60 years); * (2) patients diagnosed with CRC; * (3) patients have completed primary curative-intent treatment for colorectal cancer, and are currently in a stable post-treatment or maintenance phase of care without evidence of active disease progression or acute treatment-related instability; * (4) patients able to use a smartphone and agree to participate in the study. Exclusion Criteria: * (1) patients who have been informed of their cancer diagnosis due to family decision to withhold information; * (2) patients suffering from severe comorbidities or conditions that may affect participation or assessment, such as significant cognitive impairment (e.g., dementia, severe memory loss), psychiatric disorders, or other serious medical complications; * (3) those who are participating in other psychological intervention studies.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Kunshan First People's Hospital Affiliated to Jiangsu University Kunshan Jiangsu
The Second Affiliated Hospital of Soochow University Suzhou Jiangsu
The First Affiliated Hospital of Soochow University Suzhu Jiangsu

More The Hong Kong Polytechnic University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07611071 on ClinicalTrials.gov ↗ ← All trials in China